|75.88||+0.1000||+0.13%||Vol 8.48M||1Y Perf 21.40%|
|Apr 16th, 2021 16:00 DELAYED|
|- -||-0.08 -0.11%|
|Target Price||88.25||Analyst Rating||Moderate Buy 1.59|
|Potential %||16.30||Finscreener Ranking||★★★ 49.41|
|Insiders Trans % 3/6/12 mo.||-80/-90/-66||Value Ranking||★★+ 48.85|
|Insiders Value % 3/6/12 mo.||-99/-99/-97||Growth Ranking||★★+ 50.60|
|Insiders Shares Cnt. % 3/6/12 mo.||-99/-99/-96||Income Ranking||★+ 36.62|
|Market Cap||99.51B||Earnings Rating||Sell|
|Price Range Ratio 52W %||93.83||Earnings Date||4th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||4th May 2021|
|Estimated EPS Next Report||1.70|
|EPS Growth Next 5 Years %||6.70|
|Avg. Weekly Volume||4.52M|
|Avg. Monthly Volume||6.11M|
|Avg. Quarterly Volume||6.64M|
CVS Health Corporation (NYSE: CVS) stock closed at 75.88 per share at the end of the most recent trading day (a 0.13% change compared to the prior day closing price) with a volume of 8.51M shares and market capitalization of 99.51B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.
The one-year performance of CVS Health Corporation stock is 21.4%, while year-to-date (YTD) performance is 11.1%. CVS stock has a five-year performance of -25.15%. Its 52-week range is between 55.36 and 77.23, which gives CVS stock a 52-week price range ratio of 93.83%
CVS Health Corporation currently has a PE ratio of 13.50, a price-to-book (PB) ratio of 1.40, a price-to-sale (PS) ratio of 0.48, a price to cashflow ratio of 6.10, a PEG ratio of 2.32, a ROA of 3.04%, a ROC of 6.56% and a ROE of 10.34%. The company’s profit margin is 2.55%, its EBITDA margin is 6.40%, and its revenue ttm is $201.95 Billion , which makes it $153.87 revenue per share.
Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.70 for the next earnings report. CVS Health Corporation’s next earnings report date is 04th May 2021.
The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.59), with a target price of $88.25, which is +16.30% compared to the current price. The earnings rating for CVS Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CVS Health Corporation has a dividend yield of 2.69% with a dividend per share of $2.00 and a payout ratio of 33.00%.
CVS Health Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.24, ATR14 : 1.66, CCI20 : 107.68, Chaikin Money Flow : 0.00, MACD : 0.85, Money Flow Index : 49.24, ROC : -0.26, RSI : 58.53, STOCH (14,3) : 72.27, STOCH RSI : 1.00, UO : 59.47, Williams %R : -27.73), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan Lotvin (Buy at a value of $631 350), Alan Lotvin (Option Excercise at a value of $1 716 346), Alan Lotvin (Sold 40 112 shares of value $2 937 020 ), Alan M. Lotvin (Buy at a value of $631 350), Alan M. Lotvin (Option Excercise at a value of $3 432 692), Alan M. Lotvin (Sold 65 948 shares of value $4 874 720 ), Edward J. Ludwig (Buy at a value of $216 000), Eva C. Boratto (Option Excercise at a value of $1 402 743), Eva C. Boratto (Sold 18 882 shares of value $1 410 107 ), James D. Clark (Option Excercise at a value of $397 452), James D. Clark (Sold 11 854 shares of value $829 360 ), Jonathan C. Roberts (Option Excercise at a value of $5 455 337), Jonathan C. Roberts (Sold 73 433 shares of value $5 470 024 ), Jonathan E. Mayhew (Sold 21 112 shares of value $1 372 280 ), Joshua Flum (Option Excercise at a value of $750 242), Joshua Flum (Sold 21 460 shares of value $1 502 200 ), Larry J. Merlo (Option Excercise at a value of $49 877 858), Larry J. Merlo (Sold 667 086 shares of value $50 136 870 ), Lisa Bisaccia (Option Excercise at a value of $3 740 798), Lisa Bisaccia (Sold 50 354 shares of value $3 877 258 ), Thomas M. Moriarty (Option Excercise at a value of $4 676 035), Thomas M. Moriarty (Sold 112 154 shares of value $8 442 104 ), Troyen A. Brennan (Option Excercise at a value of $4 052 519), Troyen A. Brennan (Sold 58 896 shares of value $4 417 200 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.